share_log

3M | 10-Q: Q2 2024 Earnings Report

3M | 10-Q: Q2 2024 Earnings Report

3M | 10-Q:2024财年二季报
美股SEC公告 ·  2024/07/26 23:13

Moomoo AI 已提取核心信息

3M reported second quarter 2024 results with net income of $1.2 billion, or $2.17 per share, compared to a loss of $7.2 billion in Q2 2023. Sales decreased 0.5% year-over-year to $6.3 billion, while operating income margin improved to 20.3%. The company successfully completed the separation of its healthcare business Solventum on April 1, 2024.Operating performance showed strength across segments, with Safety & Industrial operating margins increasing to 22.2% and Transportation & Electronics margins rising to 20.0%. The company benefited from productivity initiatives, lower raw material costs, and reduced restructuring charges. However, Consumer segment sales declined 2.4% due to softer discretionary demand.The company made significant progress on strategic initiatives, including the Combat Arms Earplugs settlement with over 99% claimant participation and continued execution of its PFAS manufacturing exit plan. 3M maintained strong liquidity with $10.4 billion in cash and marketable securities as of June 30, 2024. The quarterly dividend was reset to $0.70 per share following the Solventum spin-off.
3M reported second quarter 2024 results with net income of $1.2 billion, or $2.17 per share, compared to a loss of $7.2 billion in Q2 2023. Sales decreased 0.5% year-over-year to $6.3 billion, while operating income margin improved to 20.3%. The company successfully completed the separation of its healthcare business Solventum on April 1, 2024.Operating performance showed strength across segments, with Safety & Industrial operating margins increasing to 22.2% and Transportation & Electronics margins rising to 20.0%. The company benefited from productivity initiatives, lower raw material costs, and reduced restructuring charges. However, Consumer segment sales declined 2.4% due to softer discretionary demand.The company made significant progress on strategic initiatives, including the Combat Arms Earplugs settlement with over 99% claimant participation and continued execution of its PFAS manufacturing exit plan. 3M maintained strong liquidity with $10.4 billion in cash and marketable securities as of June 30, 2024. The quarterly dividend was reset to $0.70 per share following the Solventum spin-off.
3M报告了2024年第二季度的业绩,净利润为12亿美元,或每股2.17美元,而2023年第二季度则亏损72亿美元。销售额同比下降0.5%,降至63亿美元,而营业收入率提高至20.3%。公司于2024年4月1日成功完成了其医疗业务Solventum的分拆。各个部门的运营表现强劲,安全与工业的营业利润率上升到22.2%,运输与电子的利润率上升到20.0%。公司得益于生产力举措、原材料成本降低和减少重组费用。然而,由于可自由支配需求疲软,消费部门的销售额下降了2.4%。公司在战略举措上取得了显著进展,包括Combat Arms耳塞的和解,超过99%的索赔参与率,以及PFAS制造退出计划的持续执行。截止2024年6月30日,3M保持强劲的流动性,现金及可交易证券达到104亿美元。经过Solventum分拆后,季度股息重新设定为每股0.70美元。
3M报告了2024年第二季度的业绩,净利润为12亿美元,或每股2.17美元,而2023年第二季度则亏损72亿美元。销售额同比下降0.5%,降至63亿美元,而营业收入率提高至20.3%。公司于2024年4月1日成功完成了其医疗业务Solventum的分拆。各个部门的运营表现强劲,安全与工业的营业利润率上升到22.2%,运输与电子的利润率上升到20.0%。公司得益于生产力举措、原材料成本降低和减少重组费用。然而,由于可自由支配需求疲软,消费部门的销售额下降了2.4%。公司在战略举措上取得了显著进展,包括Combat Arms耳塞的和解,超过99%的索赔参与率,以及PFAS制造退出计划的持续执行。截止2024年6月30日,3M保持强劲的流动性,现金及可交易证券达到104亿美元。经过Solventum分拆后,季度股息重新设定为每股0.70美元。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息